FILTERS

ORDER BY

HOME > BY SESSION TYPE

Selection of abstracts

Paper poster

Analytical performance evaluation of the BIOFIRE® Blood Culture Identification 2 (BCID2) Panel

Bloodstream infections: fast diagnosis using molecular tools

Evaluation of an investigation-use-only prototype of the BIOFIRE® Blood Culture Identification 2 (BCID2) Panel for detection of bacteria, yeast, and antimicrobial resistance markers from positive blood cultures

Bloodstream infections: fast diagnosis using molecular tools

High-level AmpC beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae in Dutch hospitals and livestock farms: results from the i-4-1-Health project

Antimicrobial resistance in animals, food and beyond

Evaluation of the Expanded-Coverage Staphylococcus Species Assays and Improved Methicillin Resistance Detection Algorithms of the BIOFIRE® FILMARRAY® Blood Culture Identification 2 (BCID2) Panel

Bloodstream infections: be "positive"

Comparison of Molecular Rapid Diagnostic Testing Panels for Gram-negative Bacteremia using Desirability of Outcome Ranking Management of Antimicrobial Therapy (DOOR-MAT)

Bloodstream infections: fast diagnosis using molecular tools

Comparison of Three Rapid Diagnostic Blood Culture Identification Panels for Gram-Negative Bloodstream Infections

Bloodstream infections: fast diagnosis using molecular tools

Detection of Enterobacterales and associated antimicrobial resistance genes with the BIOFIRE FILMARAY Blood Culture Identification 2 (BCID2) panel

Bloodstream infections: fast diagnosis using molecular tools

Impact of the BIOFIRE® Blood Culture Identification (BCID) Panel compared to VITEK-MS and the VITEK-2 ID/AST instrument in the diagnosis and management of bloodstream infections in a 24-hour laboratory setting

Bloodstream infections: fast diagnosis using molecular tools

Multi-center Evaluation of the BIOFIRE® FILMARRAY® Blood Culture Identification 2 Panel for the Detection of Microorganisms and Resistance Markers in Positive Blood Cultures

Bloodstream infections: fast diagnosis using molecular tools

Resolution of Discrepant Results Observed during the Clinical Evaluation of Investigational Use Only Prototype of the BIOFIRE® FILMARRAY® Blood Culture Identification 2 (BCID2) Panel

Bloodstream infections: fast diagnosis using molecular tools

The comparison of the rapid blood identification results within/after 8 hours from positive signal of blood culture bottle

Bloodstream infections: fast diagnosis using molecular tools

The use and impact of a rapid molecular assay in the diagnosis and management of bloodstream infections in Botswana: a prospective clinical trial

Bloodstream infections: fast diagnosis using molecular tools

Evaluation of the BIOFIRE® FILMARRAY® Bone and Joint Infection (BJI) Panel for the detection of microorganisms and resistance markers in synovial fluid specimens

Bone and joint infections

Clinical utility of syndromic meningitis/encephalitis testing in children

Central nervous system infections

Discrepancy results with Meningitis/Encephalitis panel BIOFIRE® in cerebrospinal fluid

Central nervous system infections

Identification of central nervous system infection in children without cerebrospinal fluid pleocytosis using a syndromic meningitis/ encephalitis panel

Central nervous system infections

Impact of a multiplex PCR in the management of viral meningitis

Central nervous system infections

Performance of the rapid molecular assay BIOFIRE® Meningitis/Encephalitis (ME) Panel for the diagnosis of CNS infections: a one-year evaluation in a tertiary care hospital

Central nervous system infections

Rapid syndromic panel for the diagnosis of infectious meningitis and encephalitis: a systematic review and meta-analysis of accuracy

Central nervous system infections

Two-year experience of meningitis/encephalitis multiplex PCR assay on cerebrospinal fluids in comparison with conventional methods: advantages and disadvantages

Central nervous system infections

Unexpectedly high false positive Haemophilus influenzae rates using a meningoencephalitis syndromic PCR panel in two tertiary centres

Central nervous system infections

Efficient inactivation of clinically relevant antimicrobial drug concentrations by two resin-containing media in simulated paediatric blood cultures

Clinical challenges and culture-based diagnostics

Performance of the NTM Elite agar* for the detection of non-tuberculous mycobacteria in sputum samples of patients with cystic fibrosis

Clinical challenges and culture-based diagnostics

Detection of colistin resistance in Pseudomonas and Acinetobacter by the ATB™ PSE EU strips

Commercial AST methods: what's new?

ETEST® Eravacycline for Antimicrobial Susceptibility Testing of Enterobacteriaceae and Enterococcus spp.: performance results from a multi-centre study

Commercial AST methods: what's new?

ETEST® Imipenem/Relebactam for Antimicrobial Susceptibility testing of Enterobacteriaceae and Pseudomonas aeruginosa: performance results from a multi-centre study

Commercial AST methods: what's new?

Luminogenic phosphatase substrate for rapid susceptibility testing of Gram positive strains

Commercial AST methods: what's new?

Multi-centre study performance results of ETEST® Delafloxacin for antimicrobial susceptibility testing against Gram-positive organisms and Pseudomonas aeruginosa

Commercial AST methods: what's new?

Evaluation of the performance of three chromogenic culture media for the detection of carbapenemase producing Enterobacterales to manage healthcare-associated infections

Culture-based approaches for carbapenemase screening and confirmation

Evaluation of Colibrí™ for antimicrobial susceptibility testing

Current challenges in laboratory automation

Evaluation of Colibrí™ for the identification of Gram negative bacilli

Current challenges in laboratory automation

PhenoMATRIX™ TAG and Colibrí™ for a faster workflow of the management of urine specimens

Current challenges in laboratory automation

Evaluation of the BACT/ALERT® VIRTUO™ in terms of time to detection, performance, workflow efficiency and impact on patient management, compared to the BACTEC™ FX automated blood culture system

Diagnosing bloodstream infection

The clinical application of BIOFIRE® Respiratory Panel in children with acute respiratory tract infections

Diagnostic aspects of non-flu respiratory viruses

Comparison of host immune responses in vivo versus ex vivo lipopolysaccharide stimulation in humans using an immune transcriptomic profiling panel

Evaluating host responses to diagnose infection

The REAnimation Low Immune Status Markers study: phenotypic and functional alterations of innate immune response in critically ill patients

Evaluating host responses to diagnose infection

Evaluation of the BIOFIRE® FILMARRAY® GI Panel in the microbiological diagnosis and management of the patient with infectious gastroenteritis

Gastrointestinal infections and molecular diagnosis

Prospective evaluation of three rapid multiplex PCR assays for the detection of gastrointestinal pathogens from stool samples

Gastrointestinal infections and molecular diagnosis

European survey of Helicobacter pylori primary resistance to antibiotics: evolution over the last 20 years

Gram-negatives behaving badly: antimicrobial resistance in non-enteric GNR

INHALE WP2: Health Economics of Nosocomial Pneumonia in UK Intensive Care Units (ICU): an exploratory study

Healthcare-associated pneumonia

Preliminary results for the evaluation of the impact of syndromic lower respiratory tract panel on antimicrobial management and infection control

Healthcare-associated pneumonia

Compatibility of the new NTM Elite agar with MALDI-TOF for direct isolation and identification of non-tuberculous mycobacteria

Increasing knowledge on NTMs

Decontamination strategies used for AFB culture significantly reduce the viability of Mycobacterium abscessus in sputum samples from patients with cystic fibrosis

Increasing knowledge on NTMs

Genomic identification of clinically relevant Mycobacterium species by target sequencing

Increasing knowledge on NTMs

Performance comparison between Rapidly Growing Mycobacteria medium for direct isolation of non-tuberculous mycobacteria, and its industrial version

Increasing knowledge on NTMs

Impact of the BIOFIRE® Gastrointestinal (GI) polymerase chain reaction panel on the clinical management of children with suspected acute bacterial – diarrhoea

JARMILA JELÍNKOVÁ MEMORIAL SESSION - Early life infections: what, when and how?

Human Endogenous Retroviruses as markers of severity in Sepsis

Markers and scores for sepsis

The REAnimation Low Immune Status Markers study: phenotypic and functional alterations of adaptive immune response in critically ill patients

Markers and scores for sepsis

Differentiation of the members of the Staphylococcus aureus complex by MALDI -TOF using the VITEK® MS platform

Mass spectrometry for microbial detection, identification and typing

Genomic characterization of Achromobacter strains by nrdA gene analysis

Mass spectrometry for microbial detection, identification and typing

Comparative analysis of kitome identification methods in viral metagenomic data

Metagenomics goes clinical

Performance of VITEK® 2 AST-GN Meropenem/Vaborbactam for Antimicrobial Susceptibility Testing of Enterobacteriaceae and Pseudomonas aeruginosa: A Multi-Center Study

MIC: are all methods equal

MYCOPLASMA IST3, a new in vitro medical device to aid the diagnosis of urogenital mycoplasma infection: performance results from an international multi-center trial

Molecular diagnosis of genital infections

The effects of introduction of a syndromic PCR sputum testing in intensive care unit pneumonia patients in a tertiary trauma centre

Molecular testing and multiplex panel approaches for diagnosis

INHALE WP4: Antibiotic Prescribing Decisions in Intensive Care: A Qualitative Study

Opportunities and tools to change prescribing behaviour

BIOFIRE® FILMARRAY® Pneumonia Panel in the evaluation of severe lower respiratory tract infections

Respiratory infections: what to expect from molecular tools?

Evaluation of a quantitative multiplex PCR panel for the diagnosis of pneumonia: how do we optimise utilisation?

Respiratory infections: what to expect from molecular tools?

Evaluation of BIOFIRE® FILMARRAY® Pneumonia Plus for the detection of pathogen bacteria in respiratory infections

Respiratory infections: what to expect from molecular tools?

Evaluation of the BIOFIRE® FILMARRAY® Pneumonia plus Panel for Rapid Diagnosis of Hospital-Acquired Pneumonia

Respiratory infections: what to expect from molecular tools?

Evaluation of the potential clinical impact of BIOFIRE® FILMARRAY® Pneumonia Plus Panel for the treatment of VAP in ICUs patients, Careggi University Hospital, Florence

Respiratory infections: what to expect from molecular tools?

Impact assessment of the results of BIOFIRE® Pneumonia plus Panel for the detection of pathogenic bacteria and individualised therapeutic targeting

Respiratory infections: what to expect from molecular tools?

Impact of respiratory panel PCR assay on antibiotic use in patients with community-acquired pneumonia admitted to intensive care unit

Respiratory infections: what to expect from molecular tools?

Laboratory evaluation of the BIOFIRE® Pneumonia plus Panel compared to standard-of-care testing at a private laboratory in Cape Town, South Africa

Respiratory infections: what to expect from molecular tools?

Microbiological performances and clinical impact of the BIOFIRE® FILMARRAY® Pneumonia Plus Panel on critically ill with severe pneumonia

Respiratory infections: what to expect from molecular tools?

Microbiological Point-of-Care analysis of endotracheal aspirate from intubated patients admitted to the intensive care unit

Respiratory infections: what to expect from molecular tools?

Microbiological validation of the BIOFIRE® Pneumonia plus Panel: a single-centre experience

Respiratory infections: what to expect from molecular tools?

Multicentre study for the evaluation of BIOFIRE® FILMARRAY® Pneumonia Plus Panel for the rapid microbiological diagnosis of low respiratory tract infections

Respiratory infections: what to expect from molecular tools?

Multinational Performance Evaluation of the BIOFIRE® FILMARRAY® Pneumonia plus Panel

Respiratory infections: what to expect from molecular tools?

Performance of a PCR-based syndromic panel compared to routine culture and microscopy in patients suspected of pneumonia

Respiratory infections: what to expect from molecular tools?

The INHALE trial: designing a prescribing algorithm to aid antibiotic choices for the BIOFIRE® FILMARRAY® Pneumonia plus (PNplus) Panel

Respiratory infections: what to expect from molecular tools?

The potential impact of molecular rapid identification of pneumonia by the BIOFIRE® Pneumonia plus Panel on antimicrobial stewardship and patient management at a large district general hospital, United Kingdom

Respiratory infections: what to expect from molecular tools?

Not all candidaemias are the same: utility of a rapid identification

The changing scenario of Candida infections

Multiplex PCR for the detection of traveller’s diarrhoea: a nested case-control study

Travel medicine and migrant health

Rapid detection of Methicillin-Resistant Staphylococcus aureus in patients with late hospital acquired/ventilator associated pneumonia

Update on surveillance of Gram-positive bacteria

Too much of a good thing? Evaluation of respiratory viral panel usage in paediatric bone marrow transplant patients

Viral respiratory infections

Relatedness of European C. difficile strains from humans, food and animals by whole genome sequencing, ribotyping and toxinotyping; results from COMBACTE-CDI

Whole genome sequencing: from molecular characterization to typing